Risks of Congestive Heart Failure and Heart Attack

Actos® is a medication prescribed to treat the symptoms of Type 2 diabetes. Studies show that people who take Actos® are at risk of developing bladder cancer and suffering serious and sometimes fatal heart problems.

If you or someone you love took Actos and suffered heart-related complications, you may be eligible for compensation for your medical expenses. Call the Actos side effects lawyers at Ferrer, Poirot & Wansbrough today at (800) 210-8503 or fill out a free initial consultation form. We’ve helped many injured or sick clients get the money they deserve, and we can help you, too.

Effects of Actos® on the Heart

On August 14, 2007, the U.S. Food and Drug Administration released a warning stating that people who take Actos have a higher risk of heart problems than people who don’t take the drug. In addition, the Los Angeles Times reported in 2010 that the risk of having a heart attack while taking Actos was 30 percent higher than while taking other diabetes drugs.

Because of its potential to cause edema—or a buildup of fluid in the body—Actos can lead to:

  • Congestive Heart Failure
    Edema makes the heart work harder to pump blood throughout the body. Over time, this can cause the heart to weaken and fail—also known as congestive heart failure. This condition is often fatal without invasive treatment, which may include a heart transplant.
  • Heart Attacks
    Because the heart is weakened by edema, patients who take Actos may suffer heart attacks—even if they have no warning signs, lifestyle factors, or prior history of heart attacks. Heart attacks can lead to long and expensive hospitalizations and weeks or even months away from work.

We’ll Fight for You

You shouldn’t have to suffer because you took a medication that was supposed to make you feel better. At Ferrer, Poirot & Wansbrough, our Actos side effects lawyers are dedicated to standing up for the rights of victims like you. Call today, and let us fight for you.

Actos® is a registered trademark of Takeda Pharmaceutical Company Limited.

This law firm is not associated with, sponsored by, or affiliated with Takeda Pharmaceutical Company Limited, the U.S. Food and Drug Administration, or the Los Angeles Times.